ClinicalTrials.Veeva

Menu

Assessment of Chilbains Occuring During Covid-19 Infection (ChilblainCOVID)

C

Centre Hospitalier Universitaire de Nice

Status

Unknown

Conditions

Skin Manifestations
COVID
Chilblains

Study type

Observational

Funder types

Other

Identifiers

NCT04344119
20dermatocovid01

Details and patient eligibility

About

Some patients infected by covid-19 develop skin manifestations. These manifestations are still not well known and there pathophysiology remain unclear. Among them, acral manifestation resembling to chilblains appears frequent and quite specific. The aim of this project is to better characterize the cutaneous manifestations occurring during Covid-19 infection with a special focus on chilblains. These acral manifestation could be due to a direct viral effect, but also to microthrombosis or vascularitis. Understanding the pathomechanisms involved could provide interesting clue for understanding not only the skin manifestations but also some of the other systemic symptoms associated to covid-19 infection. This study plan to characterize these acral manifestations by analyzing the clinical and dermoscopic patterns and to correlate them with the non-invasive vascular explorations but also immune and coagulopathy explorations that are done in the CHU of Nice in covid-19 patients.

Enrollment

30 estimated patients

Sex

All

Ages

Under 90 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • All patients with proven covid infection (using PCR, serum antibody or lung TDM) and presenting at least one cutaneous lesions that occurred during the infection.

Trial contacts and locations

1

Loading...

Central trial contact

Sylvie MALERBA; Cynthia CAILLON

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems